The Form 4 filing, an SEC report of insider stock activity, was filed on November 12, 2026. It reports a sale dated November 9, 2026, three days before the filing date.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-09 |
| Date of Latest Transaction | 2026-11-09 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 4,993 |
| Price | $235.35 |
| Total Transaction Value | $1,175,089.07 |
| Insider | |
| Ticker Symbol | RMD |
| Company | RESMED INC |
| Insider Name | Farrell Michael J. |
| Insider Title | Chairman and CEO |
| Sector - Industry | Healthcare - Medical Instruments & Supplies |
| Holdings | |
| Total Shares Owned After Transaction | 479,803 |
| Position Size Change | 1.03% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of ResMed (RMD) shares by Michael J. Farrell, the company's chairman and CEO. The transaction uses code S, which identifies a sale. The record lists one transaction.
What was the average price of the transaction?
The average sale price was $235.35 per share, rounded to cents. That average applies to the 4,993 shares sold in the reported transaction.
How did this transaction affect the insider's holdings?
He sold 4,993 shares and reported 479,803 shares owned afterward. The sale covered 1.03% of the shares he held before the trade.
What's the total transaction value?
The total sale value was $1,175,089.07, rounded to cents. That amount covers the single reported transaction dated November 9, 2026.
Are there any special circumstances around this transaction?
The record identifies a Rule 10b5-1 trading-plan reference. These plans set trading instructions in advance. The filing's footnote text was not provided, so the reference's link to this specific sale cannot be confirmed. It may reflect a reference that applies to the filing as a whole. The plan's start date and trading schedule are unknown.
For research purposes only; not investment advice.